The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

The economy and the markets are "under surveillance" as we cover the latest in finance, economics and investment.

Michael Saylor's Strategy now holds 528,185 Bitcoin worth around $35.63 billion. The company is the world's largest corporate ...

Shares of Moderna, Novavax and other biotech companies fell after FDA official Peter Marks’s resignation in protest of Robert ...

Federal Reserve Chair Jerome Powell acknowledged last week that inflation had started to rise "partly in response to tariffs.

Baldwin Insurance Group (NASDAQ:BWIN) shares advanced 3.2% in Thursday morning trading after BMO Capital Markets initiated ...

The Bay Area lost 5,200 jobs in February, a setback unleashed by the loss of hundreds of jobs for each of the region’s three ...

The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ All dollar amounts are stated in United States (U.S.) Dollars unless ...

Already reeling from years of market chaos, the announced departure of CBER chief Peter Marks sent a ripple across biopharma ...

BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in ...

Further details concerning the Offering are set out in ECN Capital’s prospectus supplement dated March 14, 2025, available on SEDAR+ at www.sedarplus.com. About ECN Capital Corp.

BMO Capital Markets’ price objective suggests a potential upside of 3.05% from the stock’s previous close. Other equities analysts also recently issued research reports about the stock.